UAMS Myeloma Center
The UAMS Myeloma Center is the most comprehensive center in the world for research and clinical care related to multiple myeloma and related diseases, such as Castleman Disease and Waldenstrom Macroglobulinemia. Our team of leading scientists and clinicians has pioneered many advances that have become standards of care, leading to improved survival rates. The Myeloma Center is known for its “bench to bedside” approach, continually translating advances in the laboratory into breakthrough clinical treatments.
Total Therapy Approach
At the core of the successful outcomes at the Myeloma Center is a treatment approach that combines chemotherapy with autologous stem cell transplantation followed by a maintenance strategy.
Learn moreMyeloma Magazine Summer 2020
You can read about the latest research and clinical care advancements in this issue of Myeloma. These include our participation in the national Prospective Multiple Myeloma Impact Study (PROMMIS) and the work of Sarah Johnson, Ph.D., focused on understanding minimal residual disease and how resistant cells can be targeted to prevent relapse.
Read MagazineMyeloma Center: Retired UAMS HR Chief Shares Myeloma Journey through Blog
Hosea Long of Little Rock recently turned 70, a milestone that for most may seem unremarkable. After all, it was not the former UAMS employee’s 100th, 90th or even his 80th birthday. But it was inspiring and incredible for him and his loved ones. Long explained why in a recent entry titled “Tomorrow starts a…
Patient and Caregiver Educational Series
Carolina Schinke, M.D. presents on “Multiple Myeloma: An Overview on Diagnosis, Staging and Response Criteria.”
Watch Video on YouTubeNews & Announcements
UAMS Researcher Delgado-Calle Awarded $1.7 Million to Study Bone Health in Myeloma Patients
LITTLE ROCK —Jesus Delgado-Calle, Ph.D., an assistant professor at the University of Arkansas for Medical Sciences (UAMS), has been awarded a National Cancer Institute grant of more than $1.7 million to study ways bone therapy might repair damaged bone and prevent or delay relapse in myeloma patients. Multiple myeloma, a cancer of the plasma cells…
Read more
UAMS Partners Card Offers Shoppers and Diners 20% Discount at About 200 Locations
About 200 shops and restaurants in central and northwest Arkansas and Conway will offer discounts Oct. 30 – Nov. 8 with Partners Card, a fundraising project of the volunteer auxiliary of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS).
Read more
Frits van Rhee, M.D., Ph.D., Named Cancer Institute Auxiliary Distinguished Honoree
From the safety and comfort of their homes, 46 guests gathered at their computers Aug. 21 to recognize one of the UAMS Winthrop P. Rockefeller Cancer Institute’s highly respected physicians: Frits van Rhee, M.D., Ph.D. At the virtual reception, van Rhee was presented with the Distinguished Honoree Award, a presentation made annually by the Cancer…
Read more
Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research
LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…
Read moreWant to read more stories like these?